ESRT
Empire State Realty Trust, Inc.
There isn't enough reported data to score ESRT yet.
ESRT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
ESRT's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for real estate companies like ESRT.
ESRT PE Valuation
ESRT has no meaningful PE right now: it lost money over the past year.
ESRT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Decline | |
| -- | |
| Limited | |
| -- |
Analysts expect ESRT's revenue to decline, with its earnings and profitability holding steady.
ESRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.01 | -105% |
| Q2 2026 | $0.02 | -92% |
| Q1 2026 | $0.21 | -30% |
| Q4 2025 | $0.25 | -11% |
| Q3 2025 | $0.21 | -19% |
| Q2 2025 | $0.24 | -4% |
| Q1 2025 | $0.30 | +3.4% |
| Q4 2024 | $0.28 | -6.7% |
ESRT has swung to a loss: it lost $0.01 per share over the past year, after a profit the year before.
ESRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $193.1M | -2.4% |
| Q2 2026 | $196.9M | +3% |
| Q1 2026 | $190.3M | +5.7% |
| Q4 2025 | $199.2M | +0.8% |
| Q3 2025 | $197.7M | -0.9% |
| Q2 2025 | $191.3M | +0.9% |
| Q1 2025 | $180.1M | -0.6% |
| Q4 2024 | $197.6M | +2.4% |
ESRT's revenue grew through 2022 and has held roughly level since: $193M last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -1.3 points |
| Q2 2026 | -70% | -89 points |
| Q1 2026 | 15% | +1.2 points |
| Q4 2025 | 18% | -4 points |
| Q3 2025 | 20% | -2.8 points |
| Q2 2025 | 18% | -2.4 points |
| Q1 2025 | 14% | -2.8 points |
| Q4 2024 | 22% | +0.6 points |
ESRT's operating margin was 19% last quarter, down 1.3 points from the same quarter a year ago.
ESRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $30.5M | -58% |
| Q2 2026 | -$11.4M | +$43.6M |
| Q1 2026 | $50.7M | +23% |
| Q4 2025 | -$8.2M | -139% |
| Q3 2025 | $72.8M | +$137.9M |
| Q2 2025 | -$55.1M | -383% |
| Q1 2025 | $41.1M | +77% |
| Q4 2024 | $21M | +$30M |
ESRT's free cash flow was $62M over the past year, down 23% from the year before. Free cash flow isn't a meaningful measure for real estate companies like ESRT.
ESRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.2M shares |
| 1 year | -0.1% | -242K shares |
| 3 years | +1.5% | +4M shares |
| 5 years | -2.7% | -7.6M shares |
| Available history | -9.3% | -27.7M shares |
ESRT has 270M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $22.8M |
| Q4 2025 | $6M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
ESRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 0.0x | Very low |
ESRT's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for real estate companies like ESRT.
ESRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 78.2 | Neutral |
ESRT's weekly RSI is 53 (neutral) and its Stochastic is 78 (neutral).
ESRT PE vs Real Estate Sector
| Metric | ESRT | Sector median | Relative |
|---|---|---|---|
| PE | 266x | 24x | 1,010% above |
| PE % | 100 | 23 | 77 pts above |
ESRT has no meaningful PE right now: it lost money over the past year.
ESRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.75 | 9.9% above |
| 20 week MA | $4.87 | 7.2% above |
| 50 week MA | $5.46 | 4.4% below |
| 100 week MA | $6.76 | 23% below |
| 200 week MA | $7.84 | 33% below |
ESRT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 33% below its 200-week average.
ESRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.8 | $9.49 | -31% |
| 2021 | $9.49 | $9.03 | -4.8% |
| 2022 | $9.03 | $6.83 | -24% |
| 2023 | $6.83 | $9.69 | +42% |
| 2024 | $9.69 | $10.2 | +5.2% |
| 2025 | $10.2 | $6.46 | -37% |
| 2026 YTD | $6.46 | $5.22 | -19% |
ESRT has finished lower in four of the last six years. It's down 19% so far in 2026.